Earnings for Nov. 10, 2020
La Jolla Pharmaceutical Co., of San Diego, reported third-quarter revenue of $9.1 million, including $7.2 million in sales of Giapreza (angiotensin II), …
Read MoreLa Jolla Pharmaceutical Co., of San Diego, reported third-quarter revenue of $9.1 million, including $7.2 million in sales of Giapreza (angiotensin II), …
Read MoreMore than 22 million Americans have contracted the virus. Get the latest headlines from the Coronavirus Press today.